Health Care [ 5/12 ] | Biotechnology [ 29/75 ]
NASDAQ | Common Stock
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.
Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder.
The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatry and neurology indications.
Bright Minds Biosciences Inc. has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin.
The company was founded in 2017 and is headquartered in New York, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 14, 25 | -0.74 Decreased by -2.15 K% | -0.88 Increased by +16.10% |
| May 15, 25 | -0.42 Decreased by -340.25% | -0.46 Increased by +8.70% |
| Feb 13, 25 | 0.01 Increased by +103.11% | -0.50 Increased by +102.00% |
| Nov 27, 24 | -0.17 Increased by +43.71% | -0.60 Increased by +71.67% |
| Aug 15, 24 | 0.04 Increased by +112.54% | - |
| May 14, 24 | -0.10 Decreased by -19.10% | - |
| Feb 12, 24 | -0.32 Decreased by -235.56% | - |
| Dec 29, 23 | -0.30 Decreased by -98.68% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 0.00 Decreased by N/A% | -5.24 M Decreased by -2.54 K% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -2.95 M Decreased by -413.88% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by N/A% | 49.61 K Increased by +102.95% | Increased by +N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -749.32 K Increased by +50.96% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | 214.92 K Increased by +114.74% | Increased by +N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -574.14 K Increased by +72.00% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 0.00 Decreased by N/A% | -1.68 M Increased by +27.88% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -1.53 M Increased by +48.40% | Decreased by N/A% Decreased by N/A% |